These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 15947768)

  • 1. Incidence of cerebral embolism after cardioversion of atrial fibrillation: a prospective study with transesophageal echocardiography and cerebral magnetic resonance imaging.
    Bernhardt P; Schmidt H; Hammerstingl C; Lüderitz B; Omran H
    J Am Soc Echocardiogr; 2005 Jun; 18(6):649-53. PubMed ID: 15947768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients at high risk with atrial fibrillation: a prospective and serial follow-up during 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging.
    Bernhardt P; Schmidt H; Hammerstingl C; Lüderitz B; Omran H
    J Am Soc Echocardiogr; 2005 Sep; 18(9):919-24. PubMed ID: 16153514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term fate of left atrial thrombi and incidence of cerebral embolism under continuous anticoagulation therapy].
    Strach K; Meyer C; Hackenbroch M; Tiemann K; Haase J; Pizulli L; Omran H; Schild H; Sommer T
    Rofo; 2005 Dec; 177(12):1706-12. PubMed ID: 16333795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation with the low-molecular-weight heparin dalteparin (Fragmin) in atrial fibrillation and TEE-guided cardioversion.
    Bechtold H; Gunzenhauser D; Sawitzki H; Fung S; Janssen D
    Z Kardiol; 2003 Jul; 92(7):532-9. PubMed ID: 12883837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
    Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation at 6 months: a randomized controlled trial.
    Klein AL; Grimm RA; Jasper SE; Murray RD; Apperson-Hansen C; Lieber EA; Black IW; Davidoff R; Erbel R; Halperin JL; Orsinelli DA; Porter TR; Stoddard MF;
    Am Heart J; 2006 Feb; 151(2):380-9. PubMed ID: 16442904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delaying cardioversion following 4-week anticoagulation in case of persistent atrial fibrillation after a transcatheter ablation procedure to reduce silent cerebral thromboembolism: a single-center pilot study.
    Pianelli M; Scaglione M; Anselmino M; Caponi D; Garcia P; Cesarani F; Toso E; Raimondo C; Halimi F; Leclercq JF; Gaita F
    J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):785-9. PubMed ID: 21941200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrillation - patients at high risk for cerebral embolism.
    Bernhardt P; Schmidt H; Sommer T; Lüderitz B; Omran H
    Clin Res Cardiol; 2006 Mar; 95(3):148-53. PubMed ID: 16598527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of transesophageal echocardiography guided cardioversion in patients with atrial fibrillation, previous left atrial thrombus and effective anticoagulation.
    Saeed M; Rahman A; Afzal A; Agoston I; Jammula P; Birnbaum Y; Ware DL; Uretsky BF; Schwarz ER; Rosanio S
    Int J Cardiol; 2006 Nov; 113(3):401-5. PubMed ID: 16822564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi.
    Manning WJ; Silverman DI; Gordon SP; Krumholz HM; Douglas PS
    N Engl J Med; 1993 Mar; 328(11):750-5. PubMed ID: 8437595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioversion in patients with left ventricular thrombus is not associated with increased thromboembolic risk.
    Bangalore S; Petre L; Herweg B; Sichrovsky T; Vragel S; Steinberg JS; Chaudhry FA
    J Am Soc Echocardiogr; 2006 Apr; 19(4):438-40. PubMed ID: 16581484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation: ACUTE trial update.
    Asher CR; Klein AL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):387-91. PubMed ID: 15071261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health status outcomes after cardioversion for atrial fibrillation: results from the Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) II Trial.
    Elliott DJ; Zhao L; Jasper SE; Lieber EA; Klein AL; Weintraub WS
    Am Heart J; 2008 Aug; 156(2):374.e1-6. PubMed ID: 18657673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of spontaneous echocontrast, 'sludge' and thrombi before cardioversion in patients with atrial fibrillation: new insights into the role of transesophageal echocardiography.
    Maltagliati A; Galli CA; Tamborini G; Celeste F; Muratori M; Pepi M
    J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):523-8. PubMed ID: 19474574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-cardioversion transesophageal echocardiography (POSTEC) strategy with the use of enoxaparin for brief anticoagulation in atrial fibrillation patients: the multicenter POSTEC trial (a pilot study).
    Sorino M; Colonna P; De Luca L; Carerj S; Oliva E; De Tommasi SM; Conti U; Iacopi F; D'Agostino C; D'Amato N; Pettinati G; Montericcio V; Cualbu A; De Luca I
    J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1034-42. PubMed ID: 18163016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with atrial fibrillation and dense spontaneous echo contrast at high risk a prospective and serial follow-up over 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging.
    Bernhardt P; Schmidt H; Hammerstingl C; Lüderitz B; Omran H
    J Am Coll Cardiol; 2005 Jun; 45(11):1807-12. PubMed ID: 15936610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of anticoagulation with unfractionated heparin plus phenprocoumon for the prevention of thromboembolic complications in cardioversion for non-valvular atrial fibrillation. Sub-analysis from the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Schmidt-Lucke C; Paar WD; Stellbrink C; Nixdorff U; Hofmann T; Meurer J; Grewe R; Daniel WG; Hanrath P; Mügge A; Klein HU; Schmidt-Lucke JA
    Thromb Res; 2007; 119(1):27-34. PubMed ID: 16443257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-limited bursts of atrial fibrillation following successful cardioversion.
    Nergårdh AK; Rosenqvist M; Frick M
    Int J Cardiol; 2007 Jun; 119(1):95-100. PubMed ID: 17064786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of silent microembolism by magnetic resonance imaging after cardioversion in atrial fibrillation.
    Vázquez M; Santos E; Rodriguez I; Pato A; Vilar M; Arias JC; Fernández R; Costas I; Ghioldi A; Sanmartin M; Tardáguila F
    Rev Esp Cardiol (Engl Ed); 2012 Feb; 65(2):139-42. PubMed ID: 22153725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymptomatic cerebral lesions during pulmonary vein isolation under uninterrupted oral anticoagulation.
    Martinek M; Sigmund E; Lemes C; Derndorfer M; Aichinger J; Winter S; Jauker W; Gschwendtner M; Nesser HJ; Pürerfellner H
    Europace; 2013 Mar; 15(3):325-31. PubMed ID: 23097222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.